معرفی
Professor Kirsten Howard is a Professor of Health Economics at the School of Public Health, University of Sydney, and Co-Director of the Leeder Centre for Health Policy, Economics and Data. She holds membership in the Charles Perkins Centre and chairs the Economics Sub-Committee of the Pharmaceutical Benefits Advisory Committee (PBAC). Her expertise spans over 30 years in health economics and policy, focusing on patient preferences, quality of life measurement, and economic evaluation across areas like cancer screening, chronic kidney disease, and Indigenous health.
Education: Holds a BSc (Hons1), MAppSc (Biopharm), MPH, MHlthEc, and PhD. Recognized as a Fellow of the Australasian College of Health Services Managers (FAHMS).
Research interests include developing wellbeing measures for Aboriginal and Torres Strait Islander populations (WM2A/WM2Y projects), pharmaceutical policy evaluation, and implementing preference-based metrics in healthcare. She leads national studies on pediatric quality of life, rural healthcare models (Virtual Rural Generalist Service), and digital health economics.
Her >420 publications emphasize patient-centered outcomes, with key contributions in discrete choice experiments and health technology assessment. Current grants focus on Aboriginal wellbeing frameworks, antimicrobial stewardship, and kidney disease navigation programs.
Awards: FAHMS Fellowship and international recognition for health preference research. Advisory roles include the NSW Patient Reported Measures Program and the International Academy of Health Preference Research.
Labs/Teams: Co-leads the Leeder Centre and collaborates with multi-disciplinary teams on projects like the What Matters 2 Adults/Youth initiatives and the NAVKIDS2 clinical trial.
